Asia Deal Watch: BeiGene Gets Chinese Rights To Two EUSA Rare Disease Therapies

 
• By Ian Haydock, Vibha Ravi, Jung Won Shin, and Joseph Haas

BeiGene licenses antibody therapeutics for Castleman’s disease and high-risk neuroblastoma.

Asia Deal Watch

More from Deals

More from Business